Dhahran, Saudi Arabia – Johns Hopkins Aramco Healthcare (JHAH) announced the appointment of Dr. Russell Hales as president of its Centers of Excellence (COEs), to advance the development of specialized healthcare in Saudi Arabia. This is in line with the goals of Saudi Vision 2030, part of the healthcare transformation program.

Dr. Hales is a highly skilled radiation oncologist and professor at the world-renowned Johns Hopkins University School of Medicine. He brings extensive leadership experience and a deep understanding of Johns Hopkins Medicine's standards, expertise, and evidence-based protocols. Dr. Hales' appointment represents a significant milestone in fulfilling JHAH's mission to adopt globally recognized best practices, enhance the quality of care, and ensure patients benefit from the benefits of receiving medical care that is both best and affordable.

Commenting on this, Dr. Russell Hales said: “The Centers of Excellence represent more than just specialized clinics. They are a unified model that shortens the patient’s treatment journey and significantly improves outcomes. We are equipping teams and charting paths to deliver the right care at the right time, within reach, by adopting Johns Hopkins Medicine’s evidence-based protocols with local insights.”

He added: "Our program is also a platform for continuing education, ensuring that Johns Hopkins Aramco Healthcare teams are kept abreast of the latest global developments while sharing knowledge about Saudi Arabia."

The Centers of Excellence model embodies Johns Hopkins Aramco Healthcare's mission to provide advanced, coordinated care accessible to communities in the Kingdom of Saudi Arabia. Under the umbrella of each center, clinical expertise and innovation are brought together within an integrated system designed to ensure the highest levels of quality and facilitate the patient journey, ensuring that all stages of care are based on a precise framework.

The first of these centers will be the Oncology Center of Excellence, which aims to transform cancer care in the Kingdom. The center focuses on breast, prostate, and colorectal cancer, which are among the most prevalent cancers in the Kingdom. The center combines multidisciplinary expertise, innovation, and Johns Hopkins medical standards to deliver precise, comprehensive care imbued with compassion.

A dedicated team works in an integrated, multidisciplinary coordination framework to oversee the patient's journey—from screening through diagnosis, to treatment, recovery, and long-term health management. This approach not only improves outcomes, but also reinforces Johns Hopkins Aramco Healthcare's commitment to placing patients at the center of care.

With the completion of the Oncology Center of Excellence, Johns Hopkins Aramco Healthcare is expanding this model to include additional specialties.

Johns Hopkins Aramco Healthcare is scheduled to participate in the Global Health 2025 in Riyadh later this month, from October 27-30. Attendees will have an exclusive opportunity and in-depth insight into the Oncology Center of Excellence, highlighting how this integrated model is leading the transformation of cancer care in the Kingdom, setting new standards for every patient, every family, and every community.

About Johns Hopkins Aramco Healthcare (JHAH)

Johns Hopkins Aramco Healthcare (JHAH), one of the Kingdom's leading healthcare providers, was established in 2014 as a global partnership between Saudi Aramco and Johns Hopkins Medicine ( JHM ). This decade-long partnership builds on Saudi Aramco's rich medical legacy since 1945, represented by the Saudi Aramco Medical Services Company (SAMSO) , and Johns Hopkins Medicine's global leadership in clinical innovation, advanced research, and world-class medical education .

The center provides world-class, patient-centered healthcare across a wide range of medical specialties, including cardiology, oncology, orthopedics, women's health, children's health, mental health, neurology, and musculoskeletal care. By combining the capabilities of Saudi Aramco with the expertise of Johns Hopkins Medicine, the center leverages innovative care models, including telemedicine, home care, and AI-powered diagnostics, to provide comprehensive, accessible healthcare services using the latest technologies to meet the needs of each individual patient .

By focusing on developing precision medicine, driving innovation in digital healthcare, and developing a skilled national workforce, Johns Hopkins Aramco Healthcare continues to meet the growing healthcare needs of the communities it serves .

-I finish-

#Corporate Data

Disclaimer for the content of press releases
The content of these press releases is provided by a third-party provider. We do not assume any responsibility for, or have any control over, such content. This content is provided on an 'as is' and 'as available' basis and has not been edited in any way. Neither we nor our affiliates are responsible for the accuracy, endorsement, or completeness of the opinions, views, information, or materials contained in this content.
Press releases are provided for informational purposes only; the content does not imply legal, investment, or tax advice, or any opinion regarding the suitability, value, or profitability of any particular portfolio or investment strategy. We, or our affiliates, will not be liable for any errors or inaccuracies in the content, or for any actions you take based on such content. You expressly agree and acknowledge that you bear full responsibility for the use of the information contained in these press releases.
To the extent permitted by applicable law, Refinitiv, its parent, subsidiaries, affiliates, and their respective shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the “Refinitiv Parties”) will not be liable (either jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to: lost profits, lost savings or revenue, whether caused by negligence, tort, contract or other liability theories, even if the Refinitiv Parties have been advised of the possibility of any such damages and losses or had actually anticipated their occurrence.